WEDNESDAY, DECEMBER 9, 2020 (OnDemand) |
Available 8:00 am CT |
|
|
|
2020 SABCS Virtual Symposium
To access the virtual site, please click here |
|
|
|
|
|
Prerecorded Sessions |
|
|
AACR Distinguished Lectureship in Breast Cancer Research
|
|
|
BRCA Research
Susan E. Hankinson, ScD
University of Massachusetts
Amherst, MA |
|
|
|
|
|
AACR Outstanding Investigator Award for Breast Cancer Research |
|
|
Sherene Loi, MBBS, FRACP, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia |
|
|
|
|
|
Susan G. Komen ® Recognizes Renowned Investigators as the 2020 Recipients of Brinker Awards for Scientific Distinction |
|
|
Brinker Award for
Scientific Distinction in Basic Science
Donald P. McDonnell, PhD
Duke University School of Medicine
Durham, NC |
|
|
Brinker Award for
Scientific Distinction in Clinical Research
Laura Esserman, MD
University California San Francisco
San Francisco, CA |
|
|
|
|
|
PLENARY LECTURES
|
|
|
Presented by SABCS and SSO - Local Regional Management Following Neoadjuvant Therapy: Minding the Knowledge Gaps
|
|
|
Elizabeth A. Mittendorf, MD, PhD
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Boston, MA |
|
|
|
|
|
Assuring Progress in Cancer Research During Challenging Times
|
|
|
Norman E. "Ned" Sharpless, MD
National Cancer Institute
Bethesda, MD |
|
|
|
|
|
MINI-SYMPOSIA |
|
|
Recent Advances in Breast Cancer Prevention
Moderator: Katherine Crew, MD, MSc
Columbia University
New York, NY
|
|
|
Is it time to implement lifestyle interventions in the oncology clinic
Melinda Irwin, MD, MPH, PhD
Yale University
New Haven, CT
What else is in the imaging: How AI can improve mammograms?
Constance Lehman, MD, PhD
Massachusetts General Hospital
Boston, MA
Beyond hormones: Newer pharmacologic approaches
Powel Brown, MD, PhD
UT MD Anderson Cancer Center
Houston, TX
|
|
|
|
|
Mechanisms of Mutagenesis in Breast Cancer
Moderator: Douglas Yee, MD
Masonic Cancer Center
University of Minnesota
Minneapolis, MN |
|
|
Aging
Mike Stratton, FMedSci, FRS
Wellcome Sanger Institute
Hinxton, United Kingdom
BRCA/HRD
Andrew Tutt, MB CHB, PhD
Institute of Cancer Research
London, United Kingdom
APOBEC
Reuben Harris, PhD
Howard Hughes Medical Institute
University of Minnesota
Minneapolis, MN
|
|
|
|
|
|
BASIC SCIENCE FORUM |
|
|
The Tumor and Immune Ecosystem of Breast Cancer
Moderator: Chonghui Cheng, MD, PhD
Baylor College of Medicine
Houston, TX
|
|
|
Spatial variance signatures/Intra-tumor zonation in TNBC
Morag Park, PhD
Goodman Cancer Research Centre
Montreal, Canada
Factors impacting the
tumor microenvironment: lessons learned from melanoma
Jennifer A. Wargo, MD, MMSc
UT MD Anderson Cancer Center
Houston, TX
|
|
|
|
|
|
CLINICAL SCIENCE FORUM |
|
|
Next Generation Sequencing in Clinical Practice
Moderator: Matthew J. Ellis, MB, BChir, BSc, PhD, FRCP
Baylor College of Medicine
Houston, TX |
|
|
Understanding current platforms
Mark E. Burkard, MD, PhD
University of Wisconsin-Madison
Madison, WI
Interpreting reports
Ben Ho Park, MD, PhD
Vanderbilt University Medical Center
Vanderbilt-Ingram Cancer Center
Nashville, TN |
|
|
|
|
|
TRANSLATIONAL SCIENCE FORUMS |
|
|
Antibody-Drug Conjugates, Better Together
Moderator: Mark Pegram, MD
Stanford University
Stanford Cancer Institute
Stanford, CA |
|
|
The making of an ADC
Paul Parren, PhD
Lava Therapeutics
Utrecht, Netherlands
Antibody Drug Conjugates: What's available now and what's on the horizon (Early development)
Aditya Bardia, MD (MBBS), MPH
Massachusetts General Hospital
Harvard Medical School
Boston, MA
|
|
|
|
|
|
Mechanisms of Response to Immune Checkpoint Therapies
Moderator: Jeffrey Rosen, PhD
Baylor College of Medicine
Houston, TX |
|
|
B-cells and
follicular T cells regulate responses to immune checkpoint inhibitors in breast
tumors and melanomas
Charles M. Perou, PhD
University of North Carolina
Chapel Hill, NC
Replication stress response defects predict responses to ICT in non-hypermutated tumors
Shiaw-Yih Lin, PhD
UT MD Anderson Cancer Center
Houston, TX
|
|
|
|
|
|
POSTERS |
|
|
|
|
|
|